Related Concept Videos
01:26COPD: Management Using Bronchodilators and Corticosteroids
1.2K
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
1.2K
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
3.4K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
3.4K
01:20COPD: Pathogenesis and Clinical Features
2.1K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
2.1K
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.3K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.3K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
4.0K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
4.0K
01:24Chronic Obstructive Pulmonary Disease
3.0K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
3.0K
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Sort by
Same author
Clinical factors associated with severely reduced health status in patients with COPD and comorbid depression/anxiety: The Swedish PRAXIS study.
NPJ primary care respiratory medicine·2026
Same author
Risk factors for COPD exacerbations and mortality, and variation between primary care settings: the PRAXIS cohort study in Sweden.
Family medicine and community health·2026
Same author
Health status and prognosis of COPD patients in relation to the FEV<sub>1</sub>/FVC ratio.
NPJ primary care respiratory medicine·2026
Related Experiment Video
Updated: May 2, 2026
07:10
Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
Published on: August 24, 2019
9.4K
Primary care COPD patients compared with large pharmaceutically-sponsored COPD studies: an UNLOCK validation study.
Annemarije L Kruis1, Björn Ställberg2, Rupert C M Jones3
1Department of Public Health and Primary Care, Leiden University Medical Centre, Leiden, The Netherlands.
Plos One
|March 7, 2014
Summary
Large clinical studies used for COPD guidelines do not reflect typical primary care patients, who differ in lung function, quality of life, and exacerbation rates. This highlights a gap in current COPD research and treatment guidelines.
Area of Science:
- Pulmonary Medicine
- Clinical Research
- Epidemiology
Background:
- Current chronic obstructive pulmonary disease (COPD) guidelines rely heavily on large, pharmaceutically-sponsored COPD studies (LPCS).
- Primary care settings manage the majority of COPD patients, yet data on their specific disease characteristics are limited.
- A significant gap exists in understanding how well LPCS represent the broader COPD population treated in primary care.
Purpose of the Study:
- To assess the external validity of six major LPCS (ISOLDE, TRISTAN, TORCH, UPLIFT, ECLIPSE, POET-COPD) against primary care COPD patient data.
- To inform future clinical practice guidelines and research by evaluating the generalizability of LPCS findings.
- To determine the eligibility of primary care COPD patients for inclusion in LPCS.
Main Methods:
- Comparison of baseline data from seven European primary care databases (n=3508) with data from six LPCS.
- Analysis of patient demographics, lung function (FEV1%), quality of life scores (SGRQ), and exacerbation rates.
- Calculation of the proportion of primary care patients eligible for inclusion in each LPCS based on defined criteria.
Main Results:
- LPCS participants were generally younger, predominantly male, had worse lung function (FEV1%), and poorer quality of life scores compared to primary care patients.
- Significant differences in GOLD stage distribution were observed between LPCS and primary care populations.
- While exacerbation rates were higher in LPCS, the proportion of primary care patients eligible for LPCS inclusion varied widely (17% to 42%).
- Novel findings revealed that 34% of mild (GOLD I) COPD patients in primary care experience at least one exacerbation annually, with 12% experiencing two or more.
Conclusions:
- Primary care COPD patients exhibit distinct characteristics regarding gender, lung function, quality of life, and exacerbation frequency compared to those in LPCS.
- Further research is necessary to clarify the efficacy of pharmacological treatments for mild to moderate COPD patients.
- Future guideline development should actively incorporate data and insights from primary care populations to enhance clinical relevance and applicability.